Alteration of microRNAs regulated by c-Myc in Burkitt lymphoma

scientific article

Alteration of microRNAs regulated by c-Myc in Burkitt lymphoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2010PLoSO...512960O
P356DOI10.1371/JOURNAL.PONE.0012960
P932PMC publication ID2945769
P698PubMed publication ID20930934
P5875ResearchGate publication ID47370937

P50authorLorenzo LeonciniQ56378267
Cristiana BellanQ56524529
Anna OnnisQ38362859
P2093author name stringGiulia De Falco
Giuseppina Antonicelli
Monica Onorati
Omar Sherman
Shaheen Sayed
P2860cites workA biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.Q51940347
Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss.Q53380068
Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas.Q54668860
Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumorsQ59530370
MYCtranslocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulationQ61641519
Clinicopathologic findings in high-grade B-cell lymphomas with typical Burkitt morphologic features but lacking the MYC translocationQ79908853
"Myc'ed messages": myc induces transcription of E2F1 while inhibiting its translation via a microRNA polycistronQ21145225
TarBase: A comprehensive database of experimentally supported animal microRNA targetsQ24537513
A uniform system for microRNA annotationQ24540187
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasisQ24613599
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodQ25938999
The functions of animal microRNAsQ27860621
c-Myc-regulated microRNAs modulate E2F1 expressionQ27861046
MicroRNAs: genomics, biogenesis, mechanism, and functionQ27861070
c-MYC: more than just a matter of life and deathQ28205057
Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancerQ28253941
Causes and consequences of microRNA dysregulation in cancerQ28258994
A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's DiseaseQ34480381
Control of growth and organ size in DrosophilaQ34488131
Host-virus interaction: a new role for microRNAsQ34573002
Myc, cell competition, and compensatory proliferationQ36215291
c-myc expression: keep the noise down!Q36305373
Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cellsQ36327408
Host-virus genome interactions: macro roles for microRNAsQ36974986
Mechanisms of microRNA deregulation in human cancerQ37249289
Expression profile of microRNAs in c-Myc induced mouse mammary tumorsQ37439539
MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors.Q39769505
B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression.Q39837455
Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146aQ40001339
Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.Q41109594
Molecular diagnosis of Burkitt's lymphomaQ45207362
Drosophila myc regulates organ size by inducing cell competitionQ47071644
dMyc transforms cells into super-competitorsQ47072112
Rare lymphoid neoplasms coexpressing B- and T-cell antigens. The role of PAX-5 gene methylation in their pathogenesisQ48003539
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectmicroRNAQ310899
Burkitt lymphomaQ1016605
P577publication date2010-09-24
P1433published inPLOS OneQ564954
P1476titleAlteration of microRNAs regulated by c-Myc in Burkitt lymphoma
P478volume5

Reverse relations

cites work (P2860)
Q35654057A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.
Q41146867An Atypical Presentation of Sporadic Jejunal Burkitt's Lymphoma.
Q36143915Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation
Q92276416Current understanding of the role and regulation of miRNAs in Burkitt lymphoma
Q38060723DNA Methylation of Tumor Suppressive miRNAs in Non-Hodgkin's Lymphomas.
Q26779821EZH2 in normal hematopoiesis and hematological malignancies
Q37977130Epidemiology: clues to the pathogenesis of Burkitt lymphoma
Q41470046HIV-1 Tat induces DNMT over-expression through microRNA dysregulation in HIV-related non Hodgkin lymphomas.
Q37723512Human and Epstein-Barr Virus miRNA Profiling as Predictive Biomarkers for Endemic Burkitt Lymphoma
Q90012325Immunoglobulin heavy variable (IgHV) gene mutation and micro-RNA expression in Burkitt's lymphoma at Moi Teaching and Referral Hospital in Western Kenya
Q46520241Immunohistochemical Profile of MYC Protein in Pediatric Small Round Blue Cell Tumors
Q44607719Integrative microRNA and mRNA deep-sequencing expression profiling in endemic Burkitt lymphoma
Q34391704Lymphomas in sub-Saharan Africa--what can we learn and how can we help in improving diagnosis, managing patients and fostering translational research?
Q26785379MYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical management
Q42703031Micro-RNA Expression and Function in Lymphomas
Q30539640MicroRNA 9-3p targets β1 integrin to sensitize claudin-low breast cancer cells to MEK inhibition
Q39580400MicroRNA expression in tumor cells from Waldenstrom's macroglobulinemia reflects both their normal and malignant cell counterparts.
Q35017255MicroRNA-9 as a novel prognostic biomarker in human laryngeal squamous cell carcinoma
Q34314082MicroRNA-9 as potential biomarker for breast cancer local recurrence and tumor estrogen receptor status
Q57814100MicroRNAs as Biomarkers of B-cell Lymphoma
Q47146703Molecular and Cytogenetic Studies in a Child with Burkitt Lymphoma and Ataxia-Telangiectasia Syndrome Harboring MYC Overexpression and Partial Trisomy 8.
Q37970680Molecular profiling of aggressive lymphomas
Q55510639Prognostic significances of overexpression MYC and/or BCL2 in R-CHOP-treated diffuse large B-cell lymphoma: A Systematic review and meta-analysis.
Q48956040Role of immunohistochemistry in the era of genetic testing in MYC-positive aggressive B-cell lymphomas: a study of 209 cases
Q37626436Suppression of microRNA-9 by mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity
Q37733947The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma
Q34406580The alteration of lipid metabolism in Burkitt lymphoma identifies a novel marker: adipophilin
Q36280547The histological and biological spectrum of diffuse large B-cell lymphoma in the World Health Organization classification
Q54323506The miR-17∼92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes.
Q26851373c-MYC-miRNA circuitry: a central regulator of aggressive B-cell malignancies
Q34635116cMyc/miR-125b-5p signalling determines sensitivity to bortezomib in preclinical model of cutaneous T-cell lymphomas
Q53618163miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma.
Q21135357miRNA expression in colon polyps provides evidence for a multihit model of colon cancer

Search more.